260
Participants
Start Date
November 30, 2023
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Hyperpolarized Xe129
Inhaled hyperpolarized 129Xe used as a signal agent for MRI of the lungs.
RECRUITING
Duke University, Durham
RECRUITING
University of Iowa, Iowa City
NOT_YET_RECRUITING
University of Illinois-Chicago, Chicago
RECRUITING
University of Kansas Medical Center, Kansas City
NOT_YET_RECRUITING
Baylor College of Medicine, Houston
NOT_YET_RECRUITING
MD Anderson Cancer Center, Houston
Collaborators (1)
Johns Hopkins University
OTHER
University of Iowa
OTHER
Duke University
OTHER
University of Illinois at Chicago
OTHER
Baylor College of Medicine
OTHER
Temple University
OTHER
University of Pennsylvania
OTHER
University of Kansas Medical Center
OTHER